U.S. Proposes Hormone Replacement Drug Label Changes

Manufacturers of hormone replacement drugs should change their labels to tell women they can raise the risk of dementia and abnormal mammograms, the U.S. government said on Tuesday.

MORE ON THIS TOPIC